BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33877299)

  • 21. Prevalence, mutational spectrum and clinical implications of clonal hematopoiesis of indeterminate potential in plasma cell dyscrasias.
    Testa S; Kumar J; Goodell AJ; Zehnder JL; Alexander KM; Sidana S; Arai S; Witteles RM; Liedtke M
    Semin Oncol; 2022 Dec; 49(6):465-475. PubMed ID: 36503855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted, Amplicon-Based, Next-Generation Sequencing to Detect Age-Related Clonal Hematopoiesis.
    Snetsinger B; Ferrone CK; Rauh MJ
    Methods Mol Biol; 2019; 2045():167-180. PubMed ID: 30941718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancer.
    Stonestrom AJ; Menghrajani KN; Devlin SM; Franch-Expósito S; Ptashkin RN; Patel SY; Spitzer B; Wu X; Jee J; Sánchez Vela P; Milbank JH; Shah RH; Mohanty AS; Brannon AR; Xiao W; Berger MF; Mantha S; Levine RL
    Blood Adv; 2024 Feb; 8(4):846-856. PubMed ID: 38147626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke.
    Arends CM; Liman TG; Strzelecka PM; Kufner A; Löwe P; Huo S; Stein CM; Piper SK; Tilgner M; Sperber PS; Dimitriou S; Heuschmann PU; Hablesreiter R; Harms C; Bullinger L; Weber JE; Endres M; Damm F
    Blood; 2023 Feb; 141(7):787-799. PubMed ID: 36441964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.
    Zink F; Stacey SN; Norddahl GL; Frigge ML; Magnusson OT; Jonsdottir I; Thorgeirsson TE; Sigurdsson A; Gudjonsson SA; Gudmundsson J; Jonasson JG; Tryggvadottir L; Jonsson T; Helgason A; Gylfason A; Sulem P; Rafnar T; Thorsteinsdottir U; Gudbjartsson DF; Masson G; Kong A; Stefansson K
    Blood; 2017 Aug; 130(6):742-752. PubMed ID: 28483762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
    Genovese G; Kähler AK; Handsaker RE; Lindberg J; Rose SA; Bakhoum SF; Chambert K; Mick E; Neale BM; Fromer M; Purcell SM; Svantesson O; Landén M; Höglund M; Lehmann S; Gabriel SB; Moran JL; Lander ES; Sullivan PF; Sklar P; Grönberg H; Hultman CM; McCarroll SA
    N Engl J Med; 2014 Dec; 371(26):2477-87. PubMed ID: 25426838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease.
    Büttner P; Böttner J; Krohn K; Baber R; Platzbecker U; Cross M; Desch S; Thiele H; Steiner S; Scheinert D; Metzeler KH; Branzan D
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.
    Acuna-Hidalgo R; Sengul H; Steehouwer M; van de Vorst M; Vermeulen SH; Kiemeney LALM; Veltman JA; Gilissen C; Hoischen A
    Am J Hum Genet; 2017 Jul; 101(1):50-64. PubMed ID: 28669404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking.
    Dawoud AAZ; Tapper WJ; Cross NCP
    Leukemia; 2020 Oct; 34(10):2660-2672. PubMed ID: 32518416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
    Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
    Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis.
    Saiki R; Momozawa Y; Nannya Y; Nakagawa MM; Ochi Y; Yoshizato T; Terao C; Kuroda Y; Shiraishi Y; Chiba K; Tanaka H; Niida A; Imoto S; Matsuda K; Morisaki T; Murakami Y; Kamatani Y; Matsuda S; Kubo M; Miyano S; Makishima H; Ogawa S
    Nat Med; 2021 Jul; 27(7):1239-1249. PubMed ID: 34239136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation.
    Chan ICC; Panchot A; Schmidt E; McNulty S; Wiley BJ; Liu J; Turner K; Moukarzel L; Wong WSW; Tran D; Beeler JS; Batchi-Bouyou AL; Machiela MJ; Karyadi DM; Krajacich BJ; Zhao J; Kruglyak S; Lajoie B; Levy S; Patel M; Kantoff PW; Mason CE; Link DC; Druley TE; Stopsack KH; Bolton KL
    Bioinformatics; 2024 Mar; 40(4):. PubMed ID: 38485690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
    Kusne Y; Fernandez J; Patnaik MM
    Semin Hematol; 2021 Oct; 58(4):226-229. PubMed ID: 34802544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer.
    Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
    J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease.
    Gumuser ED; Schuermans A; Cho SMJ; Sporn ZA; Uddin MM; Paruchuri K; Nakao T; Yu Z; Haidermota S; Hornsby W; Weeks LD; Niroula A; Jaiswal S; Libby P; Ebert BL; Bick AG; Natarajan P; Honigberg MC
    J Am Coll Cardiol; 2023 May; 81(20):1996-2009. PubMed ID: 37197843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
    Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
    Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis.
    Kar SP; Quiros PM; Gu M; Jiang T; Mitchell J; Langdon R; Iyer V; Barcena C; Vijayabaskar MS; Fabre MA; Carter P; Petrovski S; Burgess S; Vassiliou GS
    Nat Genet; 2022 Aug; 54(8):1155-1166. PubMed ID: 35835912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [TFH lymphoma and associated clonal hematopoiesis].
    Nann D; Fend F; Quintanilla-Martinez L
    Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):144-149. PubMed ID: 37870568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of age and number of mutations on the size of clonal hematopoiesis.
    Wang K; Zhang W; Yi L; Zhao M; Li PY; Fu MH; Lin R; Zhu YM; Li JF; Yang WP; Fang H; Chen Z; Cai WW; Ren RB
    Proc Natl Acad Sci U S A; 2024 Feb; 121(8):e2319364121. PubMed ID: 38359296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.